Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-14T09:45:11.908Z Has data issue: false hasContentIssue false

Chapter 10 - Fetal/Neonatal Alloimmune Thrombocytopenia

from Section 4 - Fetal Maternal Alloimmune Syndromes

Published online by Cambridge University Press:  01 February 2018

By
Michael Murphy
Edited by
Sue Pavord  and
Beverley Hunt
Sue Pavord
Affiliation:
University of Oxford
Beverley Hunt
Affiliation:
King's College London
Get access
Type
Chapter
Information
The Obstetric Hematology Manual , pp. 103 - 111
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Murphy, MF, Bussel, JB. Advances in the management of alloimmune thrombocytopenia. British Journal of Haematology 2007; 136: 366–378.CrossRefGoogle ScholarPubMed
Curtis, BR, McFarland, JG. Human platelet antigens – 2013. Vox Sanguinis 2014; 106: 93–102.CrossRefGoogle ScholarPubMed
Kamphuis, MM, Paridaans, NP, Porcelijn, L, Lopriore, E, Oepkes, D. Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review. Pediatrics 2014; 133: 715–721.CrossRefGoogle ScholarPubMed
Kamphuis, MM, Paridaans, NP, Porcelijn, L et al. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: a systematic review. British Journal of Obstetrics and Gynaecology 2010; 117: 1335–1343.Google Scholar
Spencer, JA, Burrows, RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Australian and New Zealand Journal of Obstetrics and Gynecology 2001; 41: 45–55.CrossRefGoogle ScholarPubMed
Heyu, N. Fetal and neonatal alloimmune thrombocytopenia: lessons learned from animal models. Blood Journal 2013; 122: SCI 50Google Scholar
Radder, CM, Brand, A, Kanhai, HH. Will it ever be possible to balance the risk of intracranial hemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sanguinis 2003; 84: 318–325.Google Scholar
Murphy, MF, Williamson, LM, Urbaniak, SJ. Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sanguinis 2002; 83 (Suppl 1): 409–416.CrossRefGoogle Scholar
Allen, D, Verjee, S, Rees, S, Murphy, MF, Roberts, DJ. Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood 2007; 109; 388–389.Google Scholar
Rayment, R, Brunskill, SJ, Soothill, PW, et al. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database of Systematic Reviews 2011; 5: CD004226. doi: 10.1002/14651858.Google Scholar
Bussel, JB, Berkowitz, RL, Lynch, L et al. Antenatal management of alloimmune thrombocytopenia with intravenous gammaglobulin: a randomized trial of the addition of low dose steroid to IVIg in fifty-five maternal–fetal pairs. American Journal of Obstetrics and Gynecology 1996; 174: 1414–1423.CrossRefGoogle Scholar
Berkowitz, RL, Kolb, EA, McFarland, JG et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstetrics and Gynecology 2006; 107: 91–96.CrossRefGoogle ScholarPubMed
Radder, CM, Brand, A, Kanhai, HHH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. American Journal of Obstetrics and Gynecology 2001; 185: 683–688.CrossRefGoogle ScholarPubMed
Pacheco, LD, Berkowitz, RL, Moise, KJ Jr et al. Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstetrics and Gynecology 2011; 118: 1157–1163.CrossRefGoogle ScholarPubMed
Murphy, MF, Metcalfe, P, Waters, AH et al. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Blood 1993: 81: 2174–2179.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×